Examkin

Question

Difficulty: HardPharmacologic Interventions

A 62-year-old female is hospitalized for an exacerbation of chronic obstructive pulmonary disease. She has been receiving subcutaneous unfractionated heparin for deep vein thrombosis prophylaxis. On hospital day 6, her right leg becomes acutely swollen and painful. Venous duplex ultrasonography reveals a new popliteal vein thrombosis. Her platelet count, which was 240,000/mm3240,000/\text{mm}^3 on admission, is now 95,000/mm395,000/\text{mm}^3. The clinical team suspects heparin-induced thrombocytopenia (HIT).

Arrange the following pharmacologic management steps in the strict chronological sequence required to safely treat this patient and transition her to long-term anticoagulation.

  1. 1Discontinue subcutaneous unfractionated heparin
  2. 2Initiate a continuous intravenous infusion of argatroban
  3. 3Initiate oral warfarin therapy
  4. 4Discontinue the intravenous infusion of argatroban

Answer

The correct chronological sequence is to first discontinue unfractionated heparin, immediately initiate intravenous argatroban, delay the initiation of oral warfarin until platelets recover, and finally discontinue argatroban only after an adequate overlap period with a therapeutic INR.
The precise chronological management of HIT requires stopping heparin first to remove the trigger. Second, because of the massive thrombotic risk, an alternative parenteral agent (argatroban) must be started. Third, transition to warfarin must be delayed until platelet recovery (≥150,000/mm3\geq 150,000/\text{mm}^3) to prevent venous limb gangrene. Finally, the parenteral agent is stopped only after a 5-day overlap and a stable, therapeutic INR are confirmed.

Step-by-Step Solution

1
Halt the offending agent.
Unfractionated heparin is discontinued immediately.
Continuing heparin fuels the production of immunogenic PF4-heparin complexes, perpetuating platelet activation and thrombosis.
2
Provide immediate alternative anticoagulation.
A direct thrombin inhibitor (argatroban) is initiated.
HIT is a highly hypercoagulable state. Since the patient has an acute deep vein thrombosis, therapeutic anticoagulation must be established urgently with a safe alternative.
3
Transition to oral maintenance therapy.
Warfarin is initiated strictly after the platelet count recovers to ≥150,000/mm3\geq 150,000/\text{mm}^3.
Premature warfarin initiation rapidly depletes Protein C (which has a short half-life), severely exacerbating the hypercoagulable state and risking venous limb gangrene.
4
Complete the transition.
Argatroban is discontinued.
Ensures warfarin has achieved its full therapeutic effect. The standard requirement is overlapping both drugs for ≥5\geq 5 days AND a therapeutic INR for at least 24 hours.

Key Concept

The pharmacologic transition sequence in Heparin-Induced Thrombocytopenia (HIT): Immediate cessation of heparin, prompt initiation of a direct thrombin inhibitor, and delayed initiation of warfarin until platelet recovery.
Estimated Time:1m 30s
Rate this question

Topics

Pharmacologic Interventions

More questions from this topic